Yesterday’s announcement that the global pharmaceutical giant Abbott Laboratories had agreed to pay $1.6 billion to state and federal agencies in criminal and civil fines made me furious. This is not the first time that a large drug manufacturer has been caught illegally promoting unapproved uses for one of its medicines. But the Abbott case is especially egregious because it executives exploited two vulnerable groups: persons with mental illnesses and the elderly.
The settlement ends a four-year investigation into a wide number of calculated moves by the Illinois-based company to push sales of its neurological drug Depakote into so called “off label” markets where it didn’t belong. One of the more scandalous admissions was that executives created a special sales force to promote Depakote in nursing homes. The sales force was told to push Depakote as a substitute for proper staffing since one of its side effects was turning grandma and grandpa into compliant zombies thus reducing the need to hire employees and provide decent care. “Abbott essentially preyed on…the most helpless patient populations,” one attorney noted.